These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7040093)

  • 61. [Blood plasma alpha globulin fraction and antilymphocytic serum administered to mice. Effect on host reaction to graft and graft reaction to host (author's transl)].
    Cajthamlová H; Bednarík T
    Cas Lek Cesk; 1978 Apr; 117(15):463-6. PubMed ID: 77732
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevention of graft-versus-host reaction in mice by picogram quantities of highly purified spleen-derived immunosuppressive peptide.
    Millerioux-Di Giusto L; Kiger N; Duchange N; Lenfant M
    Transplantation; 1981 Feb; 31(2):147-9. PubMed ID: 7020177
    [No Abstract]   [Full Text] [Related]  

  • 63. Inhibition of the graft-versus-host reaction. II. Prevention of acute graft-versus-host mortality by Fab fragments of antilymphocyte globulin.
    Richie ER; Gallagher MT; Trentin JJ
    Transplantation; 1973 May; 15(5):486-91. PubMed ID: 4145551
    [No Abstract]   [Full Text] [Related]  

  • 64. Toward safer marrow transplantation.
    Good RA
    N Engl J Med; 1982 Feb; 306(7):421-3. PubMed ID: 7035951
    [No Abstract]   [Full Text] [Related]  

  • 65. The influence of hostsplenectomy on the tumour allograft-promoting effectiveness of antilymphocyte serum.
    Nouza K; Nĕmec M; Dráber P
    Folia Biol (Praha); 1973; 19(4):267-72. PubMed ID: 4148074
    [No Abstract]   [Full Text] [Related]  

  • 66. Cytology and histology of haemopoietic cell transplantation under the influence of ALS in mice. II. The effect of marrow from donors pretreated with antilymphocyte serum (ALS) on the recipient.
    Thierfelder S; Rodriguez-Paradisi E; Mempel W; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):121-9. PubMed ID: 4395674
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Active suppression of host-vs-graft reaction in pregnant mice. III. Developmental kinetics, properties, and mechanism of induction of suppressor cells during first pregnancy.
    Clark DA; McDermott MR
    J Immunol; 1981 Oct; 127(4):1267-73. PubMed ID: 6456301
    [No Abstract]   [Full Text] [Related]  

  • 68. [Mechanism of a heterologous, cutaneous Graft-Versus-Host reaction in mice].
    Brune K
    Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):74-88. PubMed ID: 4391808
    [No Abstract]   [Full Text] [Related]  

  • 69. Monoclonal antibody toxin conjugates for experimental graft-versus-host disease prophylaxis. Reagents selectively reactive with T cells and not murine stem cells.
    Vallera DA; Youle RJ; Neville DM; Soderling CC; Kersey JH
    Transplantation; 1983 Jul; 36(1):73-80. PubMed ID: 6346616
    [No Abstract]   [Full Text] [Related]  

  • 70. Histopathology of a possible graft-versus-host reaction induced by nude mouse spleen cells.
    OKunewick JP; Beschorner WE; Buffo MJ; Kociban DL
    Transplantation; 1985 Apr; 39(4):447-9. PubMed ID: 3984023
    [No Abstract]   [Full Text] [Related]  

  • 71. Survival and endogenous colony formation in irradiated mice grafted with normal or infectious mononucleosis bone marrow.
    Louwagie AC; Verwilghen RL
    Experientia; 1973; 29(7):861-2. PubMed ID: 4146806
    [No Abstract]   [Full Text] [Related]  

  • 72. Influence of cell dose on mortality from graft-versus-host disease.
    Toya RE; Congdon CC
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):144-6. PubMed ID: 4396443
    [No Abstract]   [Full Text] [Related]  

  • 73. [Mechanism of a heterologous, cutaneous graft-versus-host reaction in mice. II. Reactivity of graft and host].
    Brune K; Bucher KE
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(2):73-86. PubMed ID: 4400329
    [No Abstract]   [Full Text] [Related]  

  • 74. Studies on a systemic xenogeneic graft-versus-host reaction model in newborn mice.
    Axelsson JA
    Transplantation; 1976 Oct; 22(4):349-59. PubMed ID: 10644
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of antithymocyte serum on lymph node cells participating in the graft-vs-host reaction.
    Morse HC; Asofsky R
    Cell Immunol; 1976 Jun; 24(1):69-78. PubMed ID: 7359
    [No Abstract]   [Full Text] [Related]  

  • 76. [Early lethality in adrenalectomized mice during the graft vs host reaction].
    Semenkov VF
    Dokl Akad Nauk SSSR; 1972 Apr; 203(6):1441-4. PubMed ID: 4402544
    [No Abstract]   [Full Text] [Related]  

  • 77. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host.
    Boak JL; Dagher RK; Corson JM; Wilson RE
    Clin Exp Immunol; 1968 Oct; 3(8):801-8. PubMed ID: 5718504
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modification of the second set reaction by antilymphocytic serum.
    Boak JL; Draper V; House AK; Pattisson PH
    Br J Surg; 1971 Apr; 58(4):300-1. PubMed ID: 4396709
    [No Abstract]   [Full Text] [Related]  

  • 79. From tumor-host to feto-maternal relationship. Immunological studies.
    Pasqualini CD; Piazzon I; Matusevich M; Déroche A
    Prog Clin Biol Res; 1982; 87():277-87. PubMed ID: 6981118
    [No Abstract]   [Full Text] [Related]  

  • 80. Graft-vs-host reaction in a xenogeneic combination: mechanism of the reaction.
    Constantine RI; Nakouz J; Maclean LD; Gordon J
    J Immunol; 1971 Jun; 106(6):1660-4. PubMed ID: 4397382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.